401k Plan data: ENT AND ALLERGY ASSOCIATES, LLP 401(K) PROFIT SHARING PLAN II plan

ENT AND ALLERGY ASSOCIATES, LLP 401(K) PROFIT SHARING PLAN II 401k Plan overview

Plan Name	ENT AND ALLERGY ASSOCIATES, LLP 401(K) PROFIT SHARING PLAN II
Plan identification number	004

ENT AND ALLERGY ASSOCIATES, LLP 401(K) PROFIT SHARING PLAN II Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Age/Service Weighted or new comparability or similar plan - Age/Service Weighted Plan: Allocations are based on age, service, or age and service. New comparability or similar plan: Allocations are based on participant classifications and a classification(s) consists entirely or predominantly of highly compensated employees; or the plan provides an additional allocation rate on compensation above a specified threshold, and the theshold or additional rate exceeds the maximum threshold or rate allowed under the permitted disparity rules of section 401(l).
Profit-sharing
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Plan provides for automatic enrollment in plan that has employee contributions deducted from payroll.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Plan covering Self-Employed individuals.

401k Sponsoring company profile

ENT AND ALLERGY ASSOCIATES, LLP has sponsored the creation of one or more 401k plans.

Company Name: ENT AND ALLERGY ASSOCIATES, LLP

Employer identification number (EIN): 134000192

NAIC Classification: 621111
NAIC Description: Offices of Physicians (except Mental Health Specialists)

Additional information about ENT AND ALLERGY ASSOCIATES, LLP

Jurisdiction of Incorporation: New York Department of State

Incorporation Date: 1998-04-06

Company Identification Number: 2246708

Legal Registered Office Address: ATTN: ANDREW BLUSTEIN
111 GREAT NECK RD
GREAT NECK
United States of America (USA)
11021

More information about ENT AND ALLERGY ASSOCIATES, LLP

Form 5500 Filing Information

Submission information for form 5500 for 401k plan ENT AND ALLERGY ASSOCIATES, LLP 401(K) PROFIT SHARING PLAN II

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
004 2022-01-01
004 2021-01-01
004 2020-01-01
004 2019-01-01

Plan Statistics for ENT AND ALLERGY ASSOCIATES, LLP 401(K) PROFIT SHARING PLAN II

401k plan membership statisitcs for ENT AND ALLERGY ASSOCIATES, LLP 401(K) PROFIT SHARING PLAN II

Measure Date Value
2022: ENT AND ALLERGY ASSOCIATES, LLP 401(K) PROFIT SHARING PLAN II 2022 401k membership
Total participants, beginning-of-year 2022-01-01 845
Total number of active participants reported on line 7a of the Form 5500 2022-01-01 842
Number of retired or separated participants receiving benefits 2022-01-01 0
Number of other retired or separated participants entitled to future benefits 2022-01-01 83
Total of all active and inactive participants 2022-01-01 925
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2022-01-01 3
Total participants 2022-01-01 928
Number of participants with account balances 2022-01-01 810
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2022-01-01 8
2021: ENT AND ALLERGY ASSOCIATES, LLP 401(K) PROFIT SHARING PLAN II 2021 401k membership
Total participants, beginning-of-year 2021-01-01 678
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 539
Number of retired or separated participants receiving benefits 2021-01-01 0
Number of other retired or separated participants entitled to future benefits 2021-01-01 85
Total of all active and inactive participants 2021-01-01 624
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 1
Total participants 2021-01-01 625
Number of participants with account balances 2021-01-01 612
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 9
2020: ENT AND ALLERGY ASSOCIATES, LLP 401(K) PROFIT SHARING PLAN II 2020 401k membership
Total participants, beginning-of-year 2020-01-01 669
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 529
Number of retired or separated participants receiving benefits 2020-01-01 0
Number of other retired or separated participants entitled to future benefits 2020-01-01 80
Total of all active and inactive participants 2020-01-01 609
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 1
Total participants 2020-01-01 610
Number of participants with account balances 2020-01-01 585
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 14
2019: ENT AND ALLERGY ASSOCIATES, LLP 401(K) PROFIT SHARING PLAN II 2019 401k membership
Total participants, beginning-of-year 2019-01-01 601
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 571
Number of retired or separated participants receiving benefits 2019-01-01 0
Number of other retired or separated participants entitled to future benefits 2019-01-01 20
Total of all active and inactive participants 2019-01-01 591
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 1
Total participants 2019-01-01 592
Number of participants with account balances 2019-01-01 492
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 19

Measure	Date	Value
2022: ENT AND ALLERGY ASSOCIATES, LLP 401(K) PROFIT SHARING PLAN II 2022 401k membership
Total participants, beginning-of-year	2022-01-01	845
Total number of active participants reported on line 7a of the Form 5500	2022-01-01	842
Number of retired or separated participants receiving benefits	2022-01-01	0
Number of other retired or separated participants entitled to future benefits	2022-01-01	83
Total of all active and inactive participants	2022-01-01	925
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2022-01-01	3
Total participants	2022-01-01	928
Number of participants with account balances	2022-01-01	810
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2022-01-01	8
2021: ENT AND ALLERGY ASSOCIATES, LLP 401(K) PROFIT SHARING PLAN II 2021 401k membership
Total participants, beginning-of-year	2021-01-01	678
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	539
Number of retired or separated participants receiving benefits	2021-01-01	0
Number of other retired or separated participants entitled to future benefits	2021-01-01	85
Total of all active and inactive participants	2021-01-01	624
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	1
Total participants	2021-01-01	625
Number of participants with account balances	2021-01-01	612
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	9
2020: ENT AND ALLERGY ASSOCIATES, LLP 401(K) PROFIT SHARING PLAN II 2020 401k membership
Total participants, beginning-of-year	2020-01-01	669
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	529
Number of retired or separated participants receiving benefits	2020-01-01	0
Number of other retired or separated participants entitled to future benefits	2020-01-01	80
Total of all active and inactive participants	2020-01-01	609
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	1
Total participants	2020-01-01	610
Number of participants with account balances	2020-01-01	585
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	14
2019: ENT AND ALLERGY ASSOCIATES, LLP 401(K) PROFIT SHARING PLAN II 2019 401k membership
Total participants, beginning-of-year	2019-01-01	601
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	571
Number of retired or separated participants receiving benefits	2019-01-01	0
Number of other retired or separated participants entitled to future benefits	2019-01-01	20
Total of all active and inactive participants	2019-01-01	591
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	1
Total participants	2019-01-01	592
Number of participants with account balances	2019-01-01	492
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	19

Financial Data on ENT AND ALLERGY ASSOCIATES, LLP 401(K) PROFIT SHARING PLAN II

Measure	Date	Value
2022 : ENT AND ALLERGY ASSOCIATES, LLP 401(K) PROFIT SHARING PLAN II 2022 401k financial data
Total unrealized appreciation/depreciation of assets	2022-12-31	$0
Total transfer of assets to this plan	2022-12-31	$1,197
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Total income from all sources (including contributions)	2022-12-31	$-450,309
Total loss/gain on sale of assets	2022-12-31	$0
Total of all expenses incurred	2022-12-31	$1,803,500
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2022-12-31	$1,762,835
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2022-12-31	$8,323,152
Value of total assets at end of year	2022-12-31	$55,875,245
Value of total assets at beginning of year	2022-12-31	$58,127,857
Total of administrative expenses incurred including professional, contract, advisory and management fees	2022-12-31	$40,665
Total interest from all sources	2022-12-31	$91,306
Total dividends received (eg from common stock, registered investment company shares)	2022-12-31	$816,692
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2022-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2022-12-31	$816,692
Was this plan covered by a fidelity bond	2022-12-31	Yes
Value of fidelity bond cover	2022-12-31	$500,000
If this is an individual account plan, was there a blackout period	2022-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2022-12-31	No
Contributions received from participants	2022-12-31	$2,341,685
Participant contributions at end of year	2022-12-31	$544,447
Participant contributions at beginning of year	2022-12-31	$546,233
Participant contributions at end of year	2022-12-31	$23,753
Participant contributions at beginning of year	2022-12-31	$1,329
Income. Received or receivable in cash from other sources (including rollovers)	2022-12-31	$631,094
Other income not declared elsewhere	2022-12-31	$-776
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Value of net income/loss	2022-12-31	$-2,253,809
Value of net assets at end of year (total assets less liabilities)	2022-12-31	$55,875,245
Value of net assets at beginning of year (total assets less liabilities)	2022-12-31	$58,127,857
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2022-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2022-12-31	No
Were any leases to which the plan was party in default or uncollectible	2022-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2022-12-31	$38,741,540
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2022-12-31	$41,882,622
Value of interest in pooled separate accounts at end of year	2022-12-31	$7,330,488
Value of interest in pooled separate accounts at beginning of year	2022-12-31	$7,272,049
Interest on participant loans	2022-12-31	$31,555
Interest earned on other investments	2022-12-31	$59,751
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2022-12-31	$3,884,644
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2022-12-31	$3,665,961
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2022-12-31	$-8,391,526
Net investment gain/loss from pooled separate accounts	2022-12-31	$-1,289,157
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2022-12-31	No
Was there a failure to transmit to the plan any participant contributions	2022-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2022-12-31	No
Contributions received in cash from employer	2022-12-31	$5,350,373
Employer contributions (assets) at end of year	2022-12-31	$5,350,373
Employer contributions (assets) at beginning of year	2022-12-31	$4,759,663
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2022-12-31	$1,762,835
Contract administrator fees	2022-12-31	$40,665
Did the plan have assets held for investment	2022-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2022-12-31	No
Opinion of an independent qualified public accountant for this plan	2022-12-31	Unqualified
Accountancy firm name	2022-12-31	CITRIN COOPERMAN & COMPANY, LLP
Accountancy firm EIN	2022-12-31	222428965
2021 : ENT AND ALLERGY ASSOCIATES, LLP 401(K) PROFIT SHARING PLAN II 2021 401k financial data
Total unrealized appreciation/depreciation of assets	2021-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total income from all sources (including contributions)	2021-12-31	$13,126,753
Total loss/gain on sale of assets	2021-12-31	$0
Total of all expenses incurred	2021-12-31	$3,903,032
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-12-31	$3,864,332
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-12-31	$6,642,840
Value of total assets at end of year	2021-12-31	$58,127,857
Value of total assets at beginning of year	2021-12-31	$48,904,136
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-12-31	$38,700
Total interest from all sources	2021-12-31	$92,364
Total dividends received (eg from common stock, registered investment company shares)	2021-12-31	$688,528
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2021-12-31	$688,528
Was this plan covered by a fidelity bond	2021-12-31	Yes
Value of fidelity bond cover	2021-12-31	$500,000
If this is an individual account plan, was there a blackout period	2021-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2021-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2021-12-31	No
Contributions received from participants	2021-12-31	$1,791,327
Participant contributions at end of year	2021-12-31	$546,233
Participant contributions at beginning of year	2021-12-31	$513,498
Participant contributions at end of year	2021-12-31	$1,329
Participant contributions at beginning of year	2021-12-31	$46,260
Income. Received or receivable in cash from other sources (including rollovers)	2021-12-31	$91,850
Other income not declared elsewhere	2021-12-31	$19
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Value of net income/loss	2021-12-31	$9,223,721
Value of net assets at end of year (total assets less liabilities)	2021-12-31	$58,127,857
Value of net assets at beginning of year (total assets less liabilities)	2021-12-31	$48,904,136
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-12-31	No
Were any leases to which the plan was party in default or uncollectible	2021-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2021-12-31	$41,882,622
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2021-12-31	$33,763,058
Value of interest in pooled separate accounts at end of year	2021-12-31	$7,272,049
Value of interest in pooled separate accounts at beginning of year	2021-12-31	$6,649,112
Interest on participant loans	2021-12-31	$34,199
Interest earned on other investments	2021-12-31	$58,165
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2021-12-31	$3,665,961
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2021-12-31	$3,532,072
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2021-12-31	$4,495,324
Net investment gain/loss from pooled separate accounts	2021-12-31	$1,207,678
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-12-31	No
Was there a failure to transmit to the plan any participant contributions	2021-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2021-12-31	No
Contributions received in cash from employer	2021-12-31	$4,759,663
Employer contributions (assets) at end of year	2021-12-31	$4,759,663
Employer contributions (assets) at beginning of year	2021-12-31	$4,400,136
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-12-31	$3,864,332
Contract administrator fees	2021-12-31	$38,700
Did the plan have assets held for investment	2021-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-12-31	No
Opinion of an independent qualified public accountant for this plan	2021-12-31	Unqualified
Accountancy firm name	2021-12-31	CITRIN COOPERMAN & COMPANY, LLP
Accountancy firm EIN	2021-12-31	222428965
2020 : ENT AND ALLERGY ASSOCIATES, LLP 401(K) PROFIT SHARING PLAN II 2020 401k financial data
Unrealized appreciation/depreciation of real estate assets	2020-12-31	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2020-12-31	$0
Total unrealized appreciation/depreciation of assets	2020-12-31	$0
Total transfer of assets to this plan	2020-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total income from all sources (including contributions)	2020-12-31	$10,607,792
Total loss/gain on sale of assets	2020-12-31	$0
Total of all expenses incurred	2020-12-31	$3,465,562
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$3,438,669
Expenses. Certain deemed distributions of participant loans	2020-12-31	$0
Value of total corrective distributions	2020-12-31	$0
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$5,989,817
Value of total assets at end of year	2020-12-31	$48,904,136
Value of total assets at beginning of year	2020-12-31	$41,761,906
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$26,893
Total income from rents	2020-12-31	$0
Total interest from all sources	2020-12-31	$82,432
Total dividends received (eg from common stock, registered investment company shares)	2020-12-31	$537,904
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2020-12-31	$537,904
Administrative expenses professional fees incurred	2020-12-31	$0
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$500,000
If this is an individual account plan, was there a blackout period	2020-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2020-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Amount of non-exempt transactions with any party-in-interest	2020-12-31	$0
Contributions received from participants	2020-12-31	$1,432,889
Participant contributions at end of year	2020-12-31	$513,498
Participant contributions at beginning of year	2020-12-31	$510,740
Participant contributions at end of year	2020-12-31	$46,260
Participant contributions at beginning of year	2020-12-31	$817
Income. Received or receivable in cash from other sources (including rollovers)	2020-12-31	$156,792
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2020-12-31	$60
Value of other receiveables (less allowance for doubtful accounts) at end of year	2020-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2020-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2020-12-31	$0
Other income not declared elsewhere	2020-12-31	$-1,333
Administrative expenses (other) incurred	2020-12-31	$0
Liabilities. Value of operating payables at beginning of year	2020-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Value of net income/loss	2020-12-31	$7,142,230
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$48,904,136
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$41,761,906
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Amount of loans by the plan or fixed income obligations due to the plan which were in default/classified-as-uncollectible as of the close of the plan year	2020-12-31	$0
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Amount of leases to which the plan was a party which were in default/classified-as-uncollectible during the year	2020-12-31	$0
Investment advisory and management fees	2020-12-31	$0
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-12-31	$33,763,058
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-12-31	$28,705,007
Value of interest in pooled separate accounts at end of year	2020-12-31	$6,649,112
Value of interest in pooled separate accounts at beginning of year	2020-12-31	$6,761,308
Interest on participant loans	2020-12-31	$32,463
Income. Interest from loans (other than to participants)	2020-12-31	$0
Interest earned on other investments	2020-12-31	$49,969
Income. Interest from US Government securities	2020-12-31	$0
Income. Interest from corporate debt instruments	2020-12-31	$0
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2020-12-31	$0
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2020-12-31	$3,532,072
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2020-12-31	$1,281,680
Expenses. Payments to insurance carriers foe the provision of benefits	2020-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2020-12-31	$3,380,667
Net investment gain/loss from pooled separate accounts	2020-12-31	$618,305
Net investment gain or loss from common/collective trusts	2020-12-31	$0
Net gain/loss from 103.12 investment entities	2020-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Contributions received in cash from employer	2020-12-31	$4,400,136
Employer contributions (assets) at end of year	2020-12-31	$4,400,136
Employer contributions (assets) at beginning of year	2020-12-31	$4,502,354
Income. Dividends from preferred stock	2020-12-31	$0
Income. Dividends from common stock	2020-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$3,438,609
Contract administrator fees	2020-12-31	$26,893
Liabilities. Value of benefit claims payable at beginning of year	2020-12-31	$0
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Aggregate proceeds on sale of assets	2020-12-31	$0
Aggregate carrying amount (costs) on sale of assets	2020-12-31	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2020-12-31	$0
Opinion of an independent qualified public accountant for this plan	2020-12-31	Unqualified
Accountancy firm name	2020-12-31	CITRIN COOPERMAN & COMPANY, LLP
Accountancy firm EIN	2020-12-31	222428965
2019 : ENT AND ALLERGY ASSOCIATES, LLP 401(K) PROFIT SHARING PLAN II 2019 401k financial data
Unrealized appreciation/depreciation of real estate assets	2019-12-31	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2019-12-31	$0
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total transfer of assets to this plan	2019-12-31	$19,732,788
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total income from all sources (including contributions)	2019-12-31	$23,920,314
Total loss/gain on sale of assets	2019-12-31	$0
Total of all expenses incurred	2019-12-31	$1,891,196
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$1,855,662
Expenses. Certain deemed distributions of participant loans	2019-12-31	$0
Value of total corrective distributions	2019-12-31	$0
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$19,167,812
Value of total assets at end of year	2019-12-31	$41,761,906
Value of total assets at beginning of year	2019-12-31	$0
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$35,534
Total income from rents	2019-12-31	$0
Total interest from all sources	2019-12-31	$47,976
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$630,931
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$630,931
Administrative expenses professional fees incurred	2019-12-31	$0
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$500,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Amount of non-exempt transactions with any party-in-interest	2019-12-31	$0
Contributions received from participants	2019-12-31	$1,707,857
Participant contributions at end of year	2019-12-31	$510,740
Participant contributions at end of year	2019-12-31	$817
Participant contributions at beginning of year	2019-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$12,957,601
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2019-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2019-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2019-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2019-12-31	$0
Other income not declared elsewhere	2019-12-31	$0
Administrative expenses (other) incurred	2019-12-31	$0
Liabilities. Value of operating payables at beginning of year	2019-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$22,029,118
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$41,761,906
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$0
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Amount of loans by the plan or fixed income obligations due to the plan which were in default/classified-as-uncollectible as of the close of the plan year	2019-12-31	$0
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Amount of leases to which the plan was a party which were in default/classified-as-uncollectible during the year	2019-12-31	$0
Investment advisory and management fees	2019-12-31	$0
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$28,705,007
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$0
Value of interest in pooled separate accounts at end of year	2019-12-31	$6,761,308
Value of interest in pooled separate accounts at beginning of year	2019-12-31	$0
Interest on participant loans	2019-12-31	$28,105
Income. Interest from loans (other than to participants)	2019-12-31	$0
Interest earned on other investments	2019-12-31	$19,871
Income. Interest from US Government securities	2019-12-31	$0
Income. Interest from corporate debt instruments	2019-12-31	$0
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2019-12-31	$0
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2019-12-31	$1,281,680
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2019-12-31	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2019-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$3,058,610
Net investment gain/loss from pooled separate accounts	2019-12-31	$1,014,985
Net investment gain or loss from common/collective trusts	2019-12-31	$0
Net gain/loss from 103.12 investment entities	2019-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Contributions received in cash from employer	2019-12-31	$4,502,354
Employer contributions (assets) at end of year	2019-12-31	$4,502,354
Employer contributions (assets) at beginning of year	2019-12-31	$0
Income. Dividends from preferred stock	2019-12-31	$0
Income. Dividends from common stock	2019-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$1,855,662
Contract administrator fees	2019-12-31	$35,534
Liabilities. Value of benefit claims payable at beginning of year	2019-12-31	$0
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Aggregate proceeds on sale of assets	2019-12-31	$0
Aggregate carrying amount (costs) on sale of assets	2019-12-31	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2019-12-31	$0
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	CITRIN COOPERMAN & COMPANY, LLP
Accountancy firm EIN	2019-12-31	222428965

Form 5500 Responses for ENT AND ALLERGY ASSOCIATES, LLP 401(K) PROFIT SHARING PLAN II

2022: ENT AND ALLERGY ASSOCIATES, LLP 401(K) PROFIT SHARING PLAN II 2022 form 5500 responses
2022-01-01	Type of plan entity	Single employer plan
2022-01-01	This submission is the final filing	No
2022-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2022-01-01	Plan is a collectively bargained plan	No
2022-01-01	Plan funding arrangement – Insurance	Yes
2022-01-01	Plan funding arrangement – Trust	Yes
2022-01-01	Plan benefit arrangement – Insurance	Yes
2022-01-01	Plan benefit arrangement - Trust	Yes
2021: ENT AND ALLERGY ASSOCIATES, LLP 401(K) PROFIT SHARING PLAN II 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	This submission is the final filing	No
2021-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2021-01-01	Plan is a collectively bargained plan	No
2021-01-01	Plan funding arrangement – Insurance	Yes
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement – Insurance	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: ENT AND ALLERGY ASSOCIATES, LLP 401(K) PROFIT SHARING PLAN II 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	This submission is the final filing	No
2020-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Insurance	Yes
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement – Insurance	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: ENT AND ALLERGY ASSOCIATES, LLP 401(K) PROFIT SHARING PLAN II 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	First time form 5500 has been submitted	Yes
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Insurance	Yes
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement – Insurance	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes

Insurance Providers Used on plan

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

613953

Policy instance

Insurance contract or identification number	613953
Number of Individuals Covered	928
Insurance policy start date	2022-01-01
Insurance policy end date	2022-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

533225

Policy instance

Insurance contract or identification number	533225
Number of Individuals Covered	928
Insurance policy start date	2022-01-01
Insurance policy end date	2022-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

613953

Policy instance

Insurance contract or identification number	613953
Number of Individuals Covered	625
Insurance policy start date	2021-01-01
Insurance policy end date	2021-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

533225

Policy instance

Insurance contract or identification number	533225
Number of Individuals Covered	625
Insurance policy start date	2021-01-01
Insurance policy end date	2021-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

613953

Policy instance

Insurance contract or identification number	613953
Number of Individuals Covered	610
Insurance policy start date	2020-01-01
Insurance policy end date	2020-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

533225

Policy instance

Insurance contract or identification number	533225
Number of Individuals Covered	610
Insurance policy start date	2020-01-01
Insurance policy end date	2020-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

613953

Policy instance

Insurance contract or identification number	613953
Number of Individuals Covered	592
Insurance policy start date	2019-01-01
Insurance policy end date	2019-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

533225

Policy instance

Insurance contract or identification number	533225
Number of Individuals Covered	592
Insurance policy start date	2019-01-01
Insurance policy end date	2019-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

Potentially related plans

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	ENT AND ALLERGY ASSOCIATES, LLP
Employer identification number (EIN):	134000192
NAIC Classification:	621111
NAIC Description:	Offices of Physicians (except Mental Health Specialists)

Jurisdiction of Incorporation:	New York Department of State
Incorporation Date:	1998-04-06
Company Identification Number:	2246708
Legal Registered Office Address:	ATTN: ANDREW BLUSTEIN 111 GREAT NECK RD GREAT NECK United States of America (USA) 11021